Ocular Therapeutix, Inc.

OCUL · Healthcare

$10.57

Capitalizzazione: 2.32B USDRendimento da dividendo: —
AdvanceÈ un buon momento per comprare Ocular Therapeutix, Inc.? Chiedi a Copenvest AIOttieni un'analisi Advance con AI su timing, rischio e cosa fanno gli investitori tracciati.Chiedi a Copenvest AI

Caricamento grafico…

Notizie

Ultime notizie su questo titolo

Insider Monkey3 set 2026, 11:06

Ocular Therapeutix (OCUL): Faster Path To Approval Comes With Rising Costs

GlobeNewswire1 set 2026, 11:00

Ocular Therapeutix™ to Participate in September and October Investor and Scientific Conferences

StockStory1 set 2026, 10:10

1 Cash-Heavy Stock on Our Buy List and 2 Facing Challenges

Simply Wall St.22 ago 2026, 06:10

Ocular Therapeutix (OCUL) Could Be 59% Undervalued Following Earnings Beat And AXPAXLI Progress

StockStory21 ago 2026, 19:47

Pharmaceuticals Stocks Q2 Highlights: Ocular Therapeutix (NASDAQ:OCUL)